ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 698,35
0,47%
Dow Jones
39 112,16
-0,76%
DAX
18 348,26
1,02%
Brent Oil
84,415
0,27%
Bitcoin
61 424,90
-0,62%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Athenex Inc (ATNX)

  7. Athenex Inc (ATNX) Actualités

ATNX

Athenex (ATNX)

Athenex Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ATNX
DateHeureSourceTitreSymboleSociété
23/05/202314h04Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:ATNXAthenex Inc
22/05/202322h16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ATNXAthenex Inc
14/05/202317h15GlobeNewswire Inc.Athenex, Inc. Reaches Agreement With Lenders to Pursue Expedited Sales ProcessNASDAQ:ATNXAthenex Inc
08/05/202322h34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATNXAthenex Inc
01/05/202319h00PR Newswire (US)Quantum Leap Healthcare Collaborative Announces Result of Oral Paclitaxel in Combination with a PD-1 and Carboplatin from I-SPY2 TRIAL at ASCONASDAQ:ATNXAthenex Inc
28/04/202314h11Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:ATNXAthenex Inc
20/03/202319h07Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ATNXAthenex Inc
20/03/202313h00GlobeNewswire Inc.Athenex Provides Fourth Quarter and Full Year 2022 Financial Results and Business UpdateNASDAQ:ATNXAthenex Inc
14/02/202322h25Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ATNXAthenex Inc
14/02/202314h00GlobeNewswire Inc.Athenex Announces a Reverse Stock SplitNASDAQ:ATNXAthenex Inc
02/02/202323h02Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:ATNXAthenex Inc
03/01/202314h00GlobeNewswire Inc.Athenex Announces MHRA Decision on Oral PaclitaxelNASDAQ:ATNXAthenex Inc
20/12/202214h15GlobeNewswire Inc.Athenex Announces Quantum Leap Healthcare Collaborative Reports Positive Trial Result of I-SPY2 Trial for Oral Paclitaxel in Combination with PD-1 and Carboplatin in Neoadjuvant Breast CancerNASDAQ:ATNXAthenex Inc
16/12/202214h00GlobeNewswire Inc.Athenex Exits 503B Sterile Compounding BusinessNASDAQ:ATNXAthenex Inc
09/12/202222h32Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ATNXAthenex Inc
22/11/202216h30GlobeNewswire Inc.Athenex Announces Positive Results of Special Stockholder MeetingNASDAQ:ATNXAthenex Inc
21/11/202214h00GlobeNewswire Inc.Athenex Announces Closing of the Sale of its China API BusinessNASDAQ:ATNXAthenex Inc
07/11/202204h26TipRanksSVB Securities Sticks to Their Hold Rating for Athenex (ATNX)NASDAQ:ATNXAthenex Inc
03/11/202215h56Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ATNXAthenex Inc
03/11/202212h05GlobeNewswire Inc.Athenex Announces Receipt of Positive Nasdaq Listing DeterminationNASDAQ:ATNXAthenex Inc
03/11/202212h00GlobeNewswire Inc.Athenex Provides Third Quarter 2022 Financial Results and Business UpdateNASDAQ:ATNXAthenex Inc
11/10/202215h15GlobeNewswire Inc.Athenex Files Definitive Proxy Statement for Special Stockholder MeetingNASDAQ:ATNXAthenex Inc
11/10/202214h31Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ATNXAthenex Inc
12/08/202221h56Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ATNXAthenex Inc
11/08/202210h21GlobeNewswire Inc.Athenex, Inc. Announces Pricing of $30 Million Public Offering of Common Stock and WarrantsNASDAQ:ATNXAthenex Inc
10/08/202222h01GlobeNewswire Inc.Athenex, Inc. Announces Proposed Underwritten Public Offering of Common Stock and WarrantsNASDAQ:ATNXAthenex Inc
05/08/202210h33TipRanksHere’s Why Athenex Shares Surged 70%NASDAQ:ATNXAthenex Inc
01/08/202205h31TipRanksSVB Securities Reiterates a Hold Rating on Athenex (ATNX)NASDAQ:ATNXAthenex Inc
28/07/202213h00GlobeNewswire Inc.Athenex Provides Second Quarter 2022 Financial Results and Business UpdateNASDAQ:ATNXAthenex Inc
25/07/202216h00GlobeNewswire Inc.Athenex Announces Publication of Data from Phase 3 Study Comparing Oral Paclitaxel Plus Encequidar Versus Intravenous Paclitaxel in Patients with Metastatic Breast Cancer in the Journal of Clinical OncologyNASDAQ:ATNXAthenex Inc
 Showing the most relevant articles for your search:NASDAQ:ATNX

Dernières Valeurs Consultées

COIN
BNTEETH
Bountie
NASDAQ
IDCC
InterDigital
LSE
PLUS
Plus500
BIT
UC1MXC
Unicredit Bank
BIT
P21NS4
NLBNPIT21NS4 20241218 20...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés